Pharmaceuticals - Community Register

  

Community list of not active veterinary medicinal products


WITHDRAWN  

Product information

Invented name: Eurifel RCP FeLV
Auth. number : EU/2/02/031
INN : FeLV recombinant canarypox virus (vCP97); attenuated feline panleucopenia virus (PLI IV)
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AD - Live viral vaccines
Chemical substance: QI06AD - Live viral vaccines
(See WHO ATCvet Index)
Indication: Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, F-69007 Lyon, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/03/2002 Centralised - Authorisation EMEA/V/C/67 (2002)1044 of 08/03/2002
21/11/2002 Centralised - Variation EMEA/V/C/67/N/2 (2002)4574 of 20/11/2002
18/02/2003 Centralised - Variation EMEA/V/C/67/II/1 (2003)595 of 14/02/2003
17/04/2003 Centralised - Variation EMEA/V/C/67/I/3
10/10/2003 Centralised - Variation EMEA/V/C/67/II/4 (2003)3741 of 08/10/2003
11/12/2003 Centralised - Variation EMEA/V/C/67/IA/5
Updated with Decision(2004)2935 of 23/07/2004
06/05/2004 Centralised - Variation EMEA/V/C/67/IA/6
Updated with Decision(2004)2935 of 23/07/2004
26/07/2004 Centralised - Variation EMEA/V/C/67/IA/5, 6 (2004)2935 of 23/07/2004
29/05/2007 Centralised - Withdrawal